Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 7 - What They Never Told You

Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check Out What Whales Are Doing With NVAX

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades.

Benzinga

Check Out What Whales Are Doing With NVAX

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's Why Pfizer And Novavax Shares Are Rising On Monday

Pfizer Inc. (NYSE: PFE) and Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 4.3% at $52.42 and 9.6% at $80.05 respectively. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.

Benzinga

France stalls in bid to win over the vaccine-shy with Novavax

France has begun using Novavax, a non-mRNA vaccine, to try and sway the unvaccinated as the number of Covid infections slightly increases raising concerns a sixth wave could be around the corner. But take up is slow.

Radio France Internationale

Novavax takes first steps to kids' vaccine

The Therapeutic Goods Administration has opened the door to Novavax applying in April to register its COVID-19 vaccine for children 12 and older.

AAP

Chart Wars: Between Moderna And Novavax, Which COVID Stock Will Soar Higher?

Moderna, Inc (NASDAQ: MRNA) and Novavax, Inc (NASDAQ: NVAX) were trading up over 10% and 8%, respectively, at one point on Wednesday, boosted by the S&P 500’s almost 2.6% intraday gain.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much

Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 10.65% on an annualized basis.

Benzinga

Novavax Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Novavax (NASDAQ:NVAX) reported Q4 sales of $222.20 million. Earnings fell to a loss of $846.28 million, resulting in a 162.47% decrease from last quarter.

Benzinga

What's Going On With Novavax Shares Today?

Novavax Inc (NASDAQ: NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue.

Benzinga

Novavax: Q4 Earnings Insights

Novavax (NASDAQ:NVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Novavax missed estimated earnings by 521.11%, reporting an EPS of $-11.18 versus an estimate of $-1.8.

Benzinga

Is Now The Time To Buy Stock In Novavax, Zoom Or Workhorse?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Benzinga

Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions — as it happened

Move comes as case numbers and deaths continue to fall in many nations

The Guardian - UK

Check Out What Whales Are Doing With NVAX

Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Germany to begin rollout of Novavax’s jab; New Zealand to end vaccine mandates after Omicron peak

Latest updates: Germany hopes protein-based vaccine comparable to flu jabs will help sway people sceptical of mRNA vaccines

StockNews.com

Should You Buy Novavax on the Dip?

Leading biotech company Novavax (NVAX) has received temporary approvals for the use of its COVID-19 vaccine from several countries and has filed for emergency use authorization from the U.S. FDA. However, with several high-efficacy vaccines already available in the market, will NVAX be able to successfully commercialize its COVID-19 vaccine…

ABC News

COVID reaches 'critical stage' in SA, dancing still banned ahead of Fringe and Novavax

South Australia's public health chief says dancing in public settings will stay all but banned for the start of the Fringe and the festival season, despite other states relaxing similar restrictions in recent days.

Benzinga

Novavax's COVID-19 Vaccine Scores Canadian Approval

Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

The Conversation

Haven't yet been vaccinated for COVID? Novavax might change your mind

After significant delays in production and approval, Novavax – the first protein-based vaccine against COVID approved in Australia – is now available.

Benzinga

What Are Whales Doing With Novavax

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades.

ABC News

You can now get Novavax in Australia. Here's what we know about the latest COVID-19 vaccine

Australians aged 18 and over can now get Novavax as their first and second vaccine for COVID-19. Officials are hoping that the protein-based formula will provide the "extra push" some may need to get the jab.

Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study

Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was

The Guardian - AU

Johnson receives ‘partygate’ police questionnaire – as it happened

This blog is now closed

1 … 6 7 8 9

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.